Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $501 | $353 | $287 | $458 |
| - Cash | $180 | $196 | $217 | $237 |
| + Debt | $22 | $23 | $43 | $29 |
| Enterprise Value | $343 | $179 | $113 | $250 |
| Revenue | $17 | $25 | $29 | $21 |
| % Growth | -30% | -16.6% | 39.9% | – |
| Gross Profit | $14 | $25 | $29 | $21 |
| % Margin | 80.5% | 100% | 100% | 100% |
| EBITDA | -$13 | -$11 | -$16 | -$29 |
| % Margin | -74% | -44.2% | -54.5% | -139% |
| Net Income | -$13 | -$9 | -$14 | -$30 |
| % Margin | -78.4% | -37.5% | -47.9% | -142.9% |
| EPS Diluted | -0.49 | -0.34 | -0.52 | -1.11 |
| % Growth | -44.1% | 34.6% | 53.2% | – |
| Operating Cash Flow | -$17 | -$6 | -$35 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$17 | -$6 | -$35 | -$0 |